Share-based Payment Arrangement, Expense in USD of MAXCYTE, INC. from 2019 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Maxcyte, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2019 to Q3 2025.
- Maxcyte, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $1.95M, a 42% decline year-over-year.
- Maxcyte, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $11.6M, a 13.9% decline year-over-year.
- Maxcyte, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $13.1M, a 6.41% decline from 2023.
- Maxcyte, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14M, a 19% increase from 2022.
- Maxcyte, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.8M, a 47.7% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)